Literature DB >> 1735481

Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea.

C Di Carlo1, Z Shoham, J MacDougall, A Patel, M L Hall, H S Jacobs.   

Abstract

OBJECTIVE: To examine the impact of polycystic ovaries (PCO) on bone mineral density in amenorrheic women of reproductive age.
DESIGN: A retrospective analysis and comparison of polycystic ovarian syndrome (PCOS) with non-PCOS amenorrheic women. A subgroup of patients with ultrasound (US)-diagnosed PCO was also investigated.
SETTING: Specialist clinic in reproductive endocrinology. PATIENTS, PARTICIPANTS: Six hundred ten consecutive cases, mean age of 29.8 +/- 7.5 years, with current history of amenorrhea of various causes. MAIN OUTCOME MEASURE: Bone mineral density in the lumbar spine (L1 to L4) as measured by dual energy x ray absorptiometry, in relation to PCOS, US-diagnosed PCO, and US findings of normal ovaries.
RESULTS: Amenorrheic patients with PCOS were found to be younger (P less than 0.001), with higher body mass index (P less than 0.001), were more estrogenized, as measured by endometrial thickness and uterine cross-sectional area (P less than 0.001), and had higher bone mineral density (P less than 0.001) compared with non-PCOS amenorrheic patients.
CONCLUSIONS: Patients with amenorrhea because of PCOS and those with US-diagnosed PCO have a higher bone density compared with amenorrheic patients with normal ovaries as detected by US scan.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1735481     DOI: 10.1016/s0015-0282(16)54837-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

Review 1.  Polycystic ovary syndrome: an ancient disorder?

Authors:  Ricardo Azziz; Daniel A Dumesic; Mark O Goodarzi
Journal:  Fertil Steril       Date:  2010-10-27       Impact factor: 7.329

2.  The Relationship of Metabolic Syndrome and Body Composition in Children with Premature Adrenarche: Is It Age Related?

Authors:  Kristen M Williams; Sharon E Oberfield; Chengchen Zhang; Donald J McMahon; Aviva B Sopher
Journal:  Horm Res Paediatr       Date:  2015-10-30       Impact factor: 2.852

3.  Intermittent Etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist.

Authors:  N Zamberlan; R Castello; D Gatti; M Rossini; V Braga; E Fracassi; S Adami
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study.

Authors:  Maryam Kazemi; Brittany Y Jarrett; Stephen A Parry; Anna E Thalacker-Mercer; Kathleen M Hoeger; Steven D Spandorfer; Marla E Lujan
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

5.  Association of plasma GDF-9 or GDF-15 levels with bone parameters in polycystic ovary syndrome.

Authors:  Zehra Berberoglu; Aynur Aktas; Yasemin Fidan; Ayse Canan Yazici; Yalcin Aral
Journal:  J Bone Miner Metab       Date:  2014-01-16       Impact factor: 2.626

6.  Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass.

Authors:  G Lupoli; C Di Carlo; V Nuzzo; G Vitale; D Russo; S Palomba; C Nappi
Journal:  J Endocrinol Invest       Date:  1997-09       Impact factor: 4.256

7.  Excess of nerve growth factor in the ovary causes a polycystic ovary-like syndrome in mice, which closely resembles both reproductive and metabolic aspects of the human syndrome.

Authors:  Jenny L Wilson; Weiyi Chen; Gregory A Dissen; Sergio R Ojeda; Michael A Cowley; Cecilia Garcia-Rudaz; Pablo J Enriori
Journal:  Endocrinology       Date:  2014-09-11       Impact factor: 4.736

8.  Menstrual irregularity and bone mass in premenopausal women: cross-sectional associations with testosterone and SHBG.

Authors:  Shuying Wei; Graeme Jones; Russell Thomson; Petr Otahal; Terry Dwyer; Alison Venn
Journal:  BMC Musculoskelet Disord       Date:  2010-12-29       Impact factor: 2.362

Review 9.  The impact of sex steroids on osteonecrosis of the jaw.

Authors:  Ranhee Kim; Sung Woo Kim; Hoon Kim; Seung-Yup Ku
Journal:  Osteoporos Sarcopenia       Date:  2022-06-17

10.  Bone mineral density in women with polycystic ovary syndrome.

Authors:  K Katulski; S Slawek; A Czyzyk; A Podfigurna-Stopa; K Paczkowska; N Ignaszak; N Podkowa; B Meczekalski
Journal:  J Endocrinol Invest       Date:  2014-09-23       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.